Skip to main content
Midas Edge

DarioHealth Corp

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Interim Statements of Stockholders’ Equity

​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Preferred Stock · ​ · paid-in · ​ · Accumulated · ​ · stockholders’
Three Months Ended September 30, 2024 · ​ · Number · ​ · Amount · ​ · Number · ​ · Amount · ​ · capital · ​ · deficit · ​ · equity
Balance as of June 30, 2024 (unaudited)30,024,275​$340,331​$*)-​$431,526​$(363,474)​$68,055
​​​​​​​​​​​​​​​​​​​​
Exercise of options4,005​*)-—​—​*)-​—​*)-
Extinguishment of preferred stock in connection with preferred stock modification—​——​—​(408)​408​—
Deemed dividend related to issuance of preferred stock—​——​—​2,686​(2,686)​—
Issuance of warrants to service providers—​——​—​211​—​211
Conversion of preferred stock to common stock359,375​*)-(175)​*)-​—​—​*)-
Stock-based compensation936,251​*)-—​—​2,575​—​2,575
Net loss—​——​—​—​(12,330)​(12,330)
​​​​​​​​​​​​​​​​​​​​
Balance as of September 30, 2024 (unaudited)31,323,906​$340,156​$*)-​$436,590​$(378,082)​$58,511
​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​Additional​​​​Total
​​Common Stock​Preferred Stock​paid-in​Accumulated​stockholders’
Nine Months Ended September 30, 2024​Number​Amount​Number​Amount​capital​deficit​equity
Balance as of December 31, 2023 (audited)27,191,849$318,959$*)-$407,502$(349,361)$58,144
​​​​​​​​​​​​​​​​​​​​
Exercise of options10,714​*)-—​—​*)-​—​*)-
Extinguishment of preferred stock in connection with preferred stock modification—​——​—​(12,194)​​12,194​—
Deemed dividend related to issuance of preferred stock—​——​—​7,800​​(7,800)​—
Issuance of warrants to service providers—​——​—​2,239​—​2,239
Stock-based compensation2,985,158​*)-—​—​10,967​—​10,967
Conversion of preferred stock to common stock1,136,185​*)-(1,225)​*)-​—​—​*)-
Issuance of preferred stock, net of issuance cost—​​—​22,422​​*)-​​20,206​​—​20,206
Modification of warrants​—​*)-—​—​70​—​70
Net Profit—​——​—​—​(33,115)​(33,115)
​​​​​​​​​​​​​​​​​​​​
Balance as of September 30, 2024 (unaudited)31,323,906​$340,156​$*)-​$436,590​$(378,082)​$58,511
​​​​​​​​​​​​​​​​​​​​

INTERIM STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) (Cont.)

​​​​​​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​ · Total
​ · ​ · Common Stock · ​ · Preferred Stock · ​ · paid-in · ​ · Accumulated · ​ · stockholders’
Three Months Ended September 30, 2023 · ​ · Number · ​ · Amount · ​ · Number · ​ · Amount · ​ · capital · ​ · deficit · ​ · equity
Balance as of June 30, 2023 (unaudited)26,784,674​$3​18,959​$*)-​$395,352​$(316,951)$78,404
​​​​​​​​​​​​​​​​​​​​
Exercise of options​86,983​​*)-​—​​—​​*)-​​—​​*)-
Deemed dividend related to issuance of preferred stock​—​​—​—​​—​​1,172​​(1,172)​​—
Issuance of warrants to service providers​—​​—​—​​—​​513​​—​​513
Stock-based compensation​291,200​​*)-​—​​—​​4,646​​—​​4,646
Issuance of common stock and preferred stock, net of issuance cost​52,300​​*)-​—​​—​​204​​—​​204
Net loss​—​​—​—​​—​​—​​(15,732)​​(15,732)
​​​​​​​​​​​​​​​​​​​​
Balance as of September 30, 2023 (unaudited)27,215,157​$318,959​$*)-​$401,887​$(333,855)​$68,035
​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​Additional​​​​Total
​​Common Stock​Preferred Stock​paid-in​Accumulated​stockholders’
Nine Months Ended September 30, 2023​Number​Amount​Number​Amount​capital​deficit​equity
Balance as of December 31, 2022 (audited)25,724,470$33,567$*)-$365,846$(285,850)$79,999
​​​​​​​​​​​​​​​​​​​​
Exercise of options4,800​*)-—​—​*)-​—​*)-
Exercise of warrants​86,983​*)-—​—​​*)-​​—​​*)-
Extinguishment of preferred stock in connection with preferred stock modification—​——​—​984​(984)​—
Deemed dividend related to issuance of preferred stock—​——​—​1,879​(1,879)​—
Issuance of warrants to service providers​—​——​—​1,738​—​1,738
Issuance of warrants related to loan agreement, net of issuance cost​—​——​​—​​1,389​​—​1,389
Stock-based compensation​910,642​*)-—​—​13,569​—​13,569
Conversion of preferred stock to common stock3,582​*)-(10)​—​—​—​—
Issuance of common stock and preferred stock, net of issuance cost408,043​​*)-​15,402​​*)-​​16,482​​—​16,482
Repurchase and retirement of common stock​76,637​​*)-​—​​—​​—​​—​​*)-
Net loss—​——​—​—​(45,142)​(45,142)
​​​​​​​​​​​​​​​​​​​​
Balance as of September 30, 2023 (unaudited)27,215,157​$318,959​$*)-​$401,887​$(333,855)​$68,035
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.